• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
T cell activation profiles in Kawasaki syndrome.川崎病中的T细胞活化谱。
Clin Exp Immunol. 2008 Feb;151(2):267-74. doi: 10.1111/j.1365-2249.2007.03567.x. Epub 2007 Dec 6.
2
T cell Vbeta repertoires in childhood vasculitides.儿童血管炎中的T细胞Vβ谱系
Clin Exp Immunol. 2003 Mar;131(3):517-27. doi: 10.1046/j.1365-2249.2003.02081.x.
3
T cell activation by coxsackievirus B4 antigens in type 1 diabetes mellitus: evidence for selective TCR Vbeta usage without superantigenic activity.1型糖尿病中柯萨奇病毒B4抗原对T细胞的激活:无超抗原活性的选择性TCR Vβ使用的证据
J Immunol. 2001 Sep 15;167(6):3513-20. doi: 10.4049/jimmunol.167.6.3513.
4
Changes in the peripheral blood T-Cell receptor V beta repertoire in vivo and in vitro during shigellosis.志贺氏菌病期间体内和体外外周血T细胞受体Vβ库的变化
Infect Immun. 1996 Apr;64(4):1391-9. doi: 10.1128/iai.64.4.1391-1399.1996.
5
Flow cytometric analysis of TCR Vβ repertoire in patients with 22q11.2 deletion syndrome.流式细胞术分析 22q11.2 缺失综合征患者的 TCR Vβ 库。
Scand J Immunol. 2011 Jun;73(6):577-85. doi: 10.1111/j.1365-3083.2011.02527.x.
6
Alterations in T-cell receptor Vbeta repertoire of CD4 and CD8 T lymphocytes in human immunodeficiency virus-infected children.人类免疫缺陷病毒感染儿童中CD4和CD8 T淋巴细胞T细胞受体Vβ谱的改变
Clin Diagn Lab Immunol. 2003 Jan;10(1):53-8. doi: 10.1128/cdli.10.1.53-58.2003.
7
Twenty-five types of T-cell receptor Vbeta family repertoire in patients with Kawasaki syndrome.
Eur J Pediatr. 1998 Dec;157(12):981-6. doi: 10.1007/s004310050982.
8
Flow cytometric analysis of the Vbeta repertoire in healthy controls.健康对照中Vβ库的流式细胞术分析。
Cytometry. 2000 Aug 1;40(4):336-45. doi: 10.1002/1097-0320(20000801)40:4<336::aid-cyto9>3.0.co;2-0.
9
Activin a suppresses peripheral CD8 T lymphocyte activity in acute-phase Kawasaki disease.激活素 A 可抑制川崎病急性期外周血 CD8+T 淋巴细胞的活性。
BMC Immunol. 2021 Feb 23;22(1):17. doi: 10.1186/s12865-021-00407-x.
10
Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease.静脉注射免疫球蛋白治疗反应性取决于川崎病中CD8 + T细胞的活化程度。
Clin Immunol. 2016 Oct;171:25-31. doi: 10.1016/j.clim.2016.08.012. Epub 2016 Aug 9.

引用本文的文献

1
Immunophenotype of Kawasaki Disease: Insights into Pathogenesis and Treatment Response.川崎病的免疫表型:对发病机制和治疗反应的见解
Life (Basel). 2025 Jun 25;15(7):1012. doi: 10.3390/life15071012.
2
A study on the transcriptional characteristics of novel HERV gene in the blood of children with Kawasaki disease and its correlation with the disease.川崎病患儿血液中新型人内源性逆转录病毒基因的转录特征及其与疾病的相关性研究
Microbiol Spectr. 2025 Sep 2;13(9):e0018925. doi: 10.1128/spectrum.00189-25. Epub 2025 Jul 28.
3
Blocking Superantigen-Mediated Diseases: Challenges and Future Trends.阻断超级抗原介导的疾病:挑战与未来趋势。
J Immunol Res. 2024 Jan 17;2024:2313062. doi: 10.1155/2024/2313062. eCollection 2024.
4
Single-cell RNA sequencing of peripheral blood mononuclear cells from acute Kawasaki disease patients.急性川崎病患者外周血单个核细胞的单细胞 RNA 测序。
Nat Commun. 2021 Sep 14;12(1):5444. doi: 10.1038/s41467-021-25771-5.
5
Multisystem Inflammatory Syndrome With Complete Kawasaki Disease Features Associated With SARS-CoV-2 Infection in a Young Adult. A Case Report.一名年轻成年人中与SARS-CoV-2感染相关的具有完全川崎病特征的多系统炎症综合征。病例报告。
Front Med (Lausanne). 2020 Jul 14;7:428. doi: 10.3389/fmed.2020.00428. eCollection 2020.
6
Biomarkers for Kawasaki Disease: Clinical Utility and the Challenges Ahead.川崎病的生物标志物:临床应用及面临的挑战
Front Pediatr. 2019 Jun 18;7:242. doi: 10.3389/fped.2019.00242. eCollection 2019.
7
The risk of hospitalization for respiratory tract infection (RTI) in children who are treated with high-dose IVIG in Kawasaki Disease: a nationwide population-based matched cohort study.川崎病中接受大剂量静脉注射免疫球蛋白治疗的儿童发生呼吸道感染(RTI)住院的风险:一项基于全国人群的匹配队列研究。
PeerJ. 2018 Mar 22;6:e4539. doi: 10.7717/peerj.4539. eCollection 2018.
8
T-Helper Cytokine Profiles in Patients with Kawasaki Disease.川崎病患者的辅助性T细胞细胞因子谱
Korean Circ J. 2015 Nov;45(6):516-21. doi: 10.4070/kcj.2015.45.6.516. Epub 2015 Nov 25.
9
Kawasaki disease: insights into pathogenesis and approaches to treatment.川崎病:发病机制的深入了解和治疗方法。
Nat Rev Rheumatol. 2015 Aug;11(8):475-82. doi: 10.1038/nrrheum.2015.54. Epub 2015 Apr 28.
10
Management of Kawasaki disease.川崎病的治疗。
Arch Dis Child. 2014 Jan;99(1):74-83. doi: 10.1136/archdischild-2012-302841. Epub 2013 Oct 25.

本文引用的文献

1
New developments in the search for the etiologic agent of Kawasaki disease.川崎病病原体研究的新进展。
Curr Opin Pediatr. 2007 Feb;19(1):71-4. doi: 10.1097/MOP.0b013e328012720f.
2
Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease.川崎病患者血清中抗金黄色葡萄球菌和化脓性链球菌超抗原IgM抗体的产生情况
Clin Exp Immunol. 2006 Mar;143(3):427-34. doi: 10.1111/j.1365-2249.2006.03015.x.
3
Infections and Kawasaki disease: implications for coronary artery outcome.感染与川崎病:对冠状动脉转归的影响
Pediatrics. 2005 Dec;116(6):e760-6. doi: 10.1542/peds.2005-0559.
4
Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease.川崎病外周血淋巴细胞及单核细胞/巨噬细胞的免疫特征
Clin Exp Immunol. 2005 Sep;141(3):381-7. doi: 10.1111/j.1365-2249.2005.02821.x.
5
Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.川崎病的诊断、治疗及长期管理:美国心脏协会青少年心血管疾病理事会风湿热、心内膜炎及川崎病委员会给卫生专业人员的声明
Circulation. 2004 Oct 26;110(17):2747-71. doi: 10.1161/01.CIR.0000145143.19711.78.
6
Kawasaki disease and toxic shock syndrome--at last the etiology is clear?川崎病与中毒性休克综合征——病因终于明确了?
Adv Exp Med Biol. 2004;549:191-200. doi: 10.1007/978-1-4419-8993-2_26.
7
Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.Vβ限制性T细胞与内皮细胞的黏附:超抗原依赖性血管损伤的一种机制。
Arthritis Rheum. 2004 Feb;50(2):589-97. doi: 10.1002/art.20021.
8
T cell Vbeta repertoires in childhood vasculitides.儿童血管炎中的T细胞Vβ谱系
Clin Exp Immunol. 2003 Mar;131(3):517-27. doi: 10.1046/j.1365-2249.2003.02081.x.
9
Analysis of T-cell receptor V-beta 2 in peripheral blood lymphocytes as a diagnostic marker for Kawasaki disease.外周血淋巴细胞中T细胞受体V-β2作为川崎病诊断标志物的分析
Infection. 2002 Dec;30(6):360-4. doi: 10.1007/s15010-002-3063-4.
10
Characterization of a novel staphylococcal enterotoxin-like superantigen, a member of the group V subfamily of pyrogenic toxins.一种新型葡萄球菌肠毒素样超抗原的特性分析,该超抗原为致热毒素V亚家族的成员。
Biochemistry. 2002 Nov 26;41(47):14033-40. doi: 10.1021/bi025977q.

川崎病中的T细胞活化谱。

T cell activation profiles in Kawasaki syndrome.

作者信息

Brogan P A, Shah V, Clarke L A, Dillon M J, Klein N

机构信息

Department of Rheumatology, Institute of Child Health and Great Ormond St Hospital for Children, London, UK.

出版信息

Clin Exp Immunol. 2008 Feb;151(2):267-74. doi: 10.1111/j.1365-2249.2007.03567.x. Epub 2007 Dec 6.

DOI:10.1111/j.1365-2249.2007.03567.x
PMID:18070150
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2276940/
Abstract

Superantigens (SAgs) are potent stimulators of T cells bearing specific Vbeta T cell receptors (TCR) and may play a role in the pathogenesis of Kawasaki syndrome (KS), although despite 15 years of intense study this area remains controversial. Because SAgs can cause Vbeta restricted T cell activation in the absence of Vbeta skewing the aims of this study were to describe a flow cytometric protocol to study both CD4 and CD8 Vbeta repertoires, and CD69 expression across the CD4 and CD8 Vbeta repertoire in children with KS. Sixteen children with KS were studied. There was no significant increase in overall peripheral blood CD4 or CD8 T cell activation as determined by CD69 expression. However, Vbeta restricted CD4 and/or CD8 activation was observed in eight of 11 (72%) of the KS patients, a finding not observed in healthy controls. Thirteen of 16 (81%) of the KS patients had evidence of either Vbeta skewing (particularly CD4 Vbeta2 and Vbeta5.1) and/or Vbeta restricted activation. Three patients had Vbeta restricted activation in the absence of skewing. We suggest that these preliminary observations highlight the many layers of complexity when considering T cell activation in KS, which could explain some of the conflicting studies regarding peripheral blood T cell activation and Vbeta skewing. It is likely that in order to move forward with this debate a combination of detailed microbiological, immunological and molecular techniques applied to individual patients will be required ultimately to prove or refute the SAg hypothesis of KS.

摘要

超抗原(SAgs)是带有特定VβT细胞受体(TCR)的T细胞的强效刺激剂,可能在川崎病(KS)的发病机制中起作用,尽管经过15年的深入研究,该领域仍存在争议。由于超抗原可在不存在Vβ偏斜的情况下引起Vβ限制性T细胞活化,本研究的目的是描述一种流式细胞术方案,以研究KS患儿的CD4和CD8 Vβ库,以及CD4和CD8 Vβ库中的CD69表达。对16名KS患儿进行了研究。通过CD69表达确定,外周血中总的CD4或CD8 T细胞活化没有显著增加。然而,在11名KS患者中的8名(72%)中观察到Vβ限制性CD4和/或CD8活化,这一发现未在健康对照中观察到。16名KS患者中的13名(81%)有Vβ偏斜(特别是CD4 Vβ2和Vβ5.1)和/或Vβ限制性活化的证据。3名患者在没有偏斜的情况下有Vβ限制性活化。我们认为,这些初步观察结果突出了在考虑KS中的T细胞活化时存在的许多复杂层面,这可以解释一些关于外周血T细胞活化和Vβ偏斜的相互矛盾的研究。为了推进这场辩论,最终可能需要将详细的微生物学、免疫学和分子技术结合应用于个体患者,以证明或反驳KS的超抗原假说。